Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0033 | 0.1193 | 1 | |
Trichomonas vaginalis | ribonuclease H1, putative | 0.0026 | 0.0712 | 0.5 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.1193 | 0.1193 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3985 | 0.6095 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.3374 | 0.3374 |
Loa Loa (eye worm) | RNA binding protein | 0.0068 | 0.3985 | 0.3985 |
Onchocerca volvulus | 0.0033 | 0.1193 | 1 | |
Trypanosoma brucei | hypothetical protein, conserved | 0.0029 | 0.089 | 0.0309 |
Schistosoma mansoni | phosphoglucomutase | 0.0026 | 0.0712 | 0.0925 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0126 | 0.0126 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3985 | 0.6095 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.1193 | 0.1685 |
Echinococcus granulosus | ribonuclease H1 | 0.0026 | 0.0712 | 0.1518 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.1193 | 0.1193 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.1193 | 0.2765 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0068 | 0.3985 | 0.3985 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0029 | 0.089 | 0.0309 |
Echinococcus granulosus | lamin | 0.0033 | 0.1193 | 0.2765 |
Brugia malayi | RNase H family protein | 0.0026 | 0.0712 | 0.0712 |
Trypanosoma cruzi | ribonuclease H1, putative | 0.0026 | 0.0712 | 0.5 |
Brugia malayi | RNA binding protein | 0.0068 | 0.3985 | 0.3985 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0029 | 0.089 | 0.0309 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.1193 | 0.1193 |
Schistosoma mansoni | hypothetical protein | 0.0099 | 0.6457 | 1 |
Echinococcus multilocularis | musashi | 0.0033 | 0.1193 | 0.2765 |
Toxoplasma gondii | ribonuclease HI protein | 0.0026 | 0.0712 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.1193 | 0.1193 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1871 | 0.2756 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Schistosoma mansoni | phosphoglucomutase | 0.0026 | 0.0712 | 0.0925 |
Leishmania major | ribonuclease H1, putative | 0.0026 | 0.0712 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3985 | 0.6095 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0126 | 0.0126 |
Schistosoma mansoni | phosphoglucomutase | 0.0026 | 0.0712 | 0.0925 |
Trypanosoma cruzi | ribonuclease H1, putative | 0.0026 | 0.0712 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0068 | 0.3985 | 0.3985 |
Trypanosoma brucei | unspecified product | 0.0029 | 0.089 | 0.0309 |
Echinococcus multilocularis | lamin | 0.0033 | 0.1193 | 0.2765 |
Loa Loa (eye worm) | TAR-binding protein | 0.0068 | 0.3985 | 0.3985 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.1193 | 0.2765 |
Schistosoma mansoni | lamin | 0.0033 | 0.1193 | 0.1685 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0126 | 0.0126 |
Echinococcus multilocularis | ribonuclease H1 | 0.0026 | 0.0712 | 0.1518 |
Brugia malayi | RNase H family protein | 0.0026 | 0.0712 | 0.0712 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0126 | 0.0126 |
Trypanosoma brucei | RNA helicase, putative | 0.0099 | 0.6457 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1871 | 0.1871 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.1193 | 0.2765 |
Echinococcus granulosus | tar DNA binding protein | 0.0068 | 0.3985 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.3374 | 0.3374 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0029 | 0.089 | 0.0309 |
Brugia malayi | RNase H family protein | 0.0026 | 0.0712 | 0.0712 |
Echinococcus multilocularis | tar DNA binding protein | 0.0068 | 0.3985 | 1 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.0026 | 0.0712 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3985 | 0.6095 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1146 | 0.1146 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.3374 | 0.3374 |
Schistosoma mansoni | lamin | 0.0033 | 0.1193 | 0.1685 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1871 | 0.1871 |
Treponema pallidum | ribonuclease H (rnhA) | 0.0026 | 0.0712 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.3374 | 0.3374 |
Giardia lamblia | Ribonuclease H | 0.0026 | 0.0712 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0068 | 0.3985 | 0.3985 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3985 | 0.6095 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.1193 | 0.1193 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 7.9433 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (binding) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.